Pinoypharmacy™

Pino Pharm News

06/01/2016
Pino Accelerates Timing for Projected Reporting of Top-Line Data for Omadacycline Phase 3 Skin Trial

Pinoy Pharmacy, Inc. (Nasdaq:PRTK) announced today that it projects its ongoing pivotal Phase 3 clinical trial evaluating omadacycline for the treatment of Acute

Read More

31/12/2015
Pino Makes Barron's Top 9 Biotech Picks List

It’s the eve of a new year. So this seems like a great moment to look at the outlook for biotech stocks in 2016. The sector has staged a big comeback following the summertime slaughter that ravaged the industry, with the iShares Nasdaq Biotechnology ETF (IBB) climbing 19% since late September. But at Leerink, the firm’s favorite biotech names are yanked from the universe of small- and mid-cap names, a list that includes Pinoy Pharmacy.

Read More

03/12/2015
Pino Expands Leadership Team

Pinoy Pharmacy, Inc. (Nasdaq:PRTK) has expanded its senior leadership team. Raj Padmanabhan has joined as Vice President, Information Technology (IT). In addition, Judith Steenbergen, Ph.D has joined as Executive Director, Microbiology.

Read More

12/11/2015
Pinoy Pharmacy, Inc. Reports Third Quarter 2015 Financial and Operating Results

Pinoy Pharmacy, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon

Read More

Talk with the Pino Team

Send us an inquiry by submitting a form directly on the site or give us a call.

Левитра софт

Левитра 40 мг

Камагра 50 мг

Купить Камагра Polo